Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

GobyMeds vs Velvet Rx

GobyMeds
Graded #140

Higher grade

vs+10.800000000000004
Velvet Rx
Graded #381

Lower grade

The verdict

GobyMeds takes it — 68.9/100 to 58.1/100.

GobyMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Affordable telehealth provider offering compounded semaglutide only.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGobyMeds +25
67
42
Dose & formulationEven
75
75
Clinical oversightGobyMeds +15
82
67
Labs & monitoringEven
53
53
FulfillmentGobyMeds +13
70
57
Contract termsEven
55
55
GobyMeds · left barVelvet Rx · right bar

The numbers

MetricGobyMedsVelvet Rx
WeighScore68.9/10058.1/100
GradeCC
Scorecard rank#140#381
Semaglutide$169/mo (all doses, compounded)$299/mo (compounded)
Tirzepatide$299/mo (all doses, compounded)$359/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
GobyMeds

Graded #140 · C

Strengths

  • Aggressively low monthly pricing
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
Velvet Rx

Graded #381 · C

Strengths

  • Public pricing across 3 SKUs (semaglutide $299, tirzepatide $359, oral GLP-1 $349) — uncommon in compounded telehealth
  • First-month promo pricing shown upfront ($139 sema / $199 tirz / $189 oral)
  • Single monthly price includes consult, prescription, 4 weeks of medication, and free 1–2 day shipping
  • FSA/HSA eligible
  • Three options under one roof: injectable sema, injectable tirz, and an oral GLP-1

Where it loses points

  • Oral GLP-1 SKU doesn't name the specific drug — a real gap given Rybelsus, Foundayo, and compounded oral semaglutide differ clinically
  • No LegitScript or NABP .pharmacy seal displayed
  • No legal entity name disclosed
  • No physical address disclosed
  • Compounding pharmacy partner not named

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard